for Fmoc group deprotection as previously described. 18 The final products were obtained in solution starting from the intermediate peptide, which was firstly converted in its tertbutylamide at the C-terminal, the Boc group removed in acidic conditions and then submitted to the following peptide elongation. The purity was found to be ≥ 95% by RP-HPLC. Nuclear magnetic resonance (NMR) spectra of the final compounds were recorded on a Varian Inova 300MHz spectrometer using DMSO-d6 as solvent. The mass spectrometry (MS) system used consisted of an LCQ (Thermo Finnigan) ion trap mass spectrometer (San Jose, CA) equipped with an electrospray ionization (ESI) source. The capillary temperature was set at 300 °C and the spray voltage at 4.25 kV. The fluid was nebulized using nitrogen (N 2 ) as both the sheath gas and the auxiliary gas. Purification of compounds was carried out by RP-HPLC using a Waters XBridge Prep BEH130 C18, 5.0 μm, 250 mm × 10 mm column at a flow rate of 4.0 mL/min on a Waters Binary pump 1525, and a linear gradient of H 2 O/acetonitrile 0.1% TFA ranging from 5% acetonitrile to 90% acetonitrile for 45 min.
In vitro Biological evaluation Chemicals
Tris-HCl, EGTA, NaCl, MgCl 2 , GDP, the GTP analogue GTPγS were purchased from Sigma-Aldrich (Budapest, Hungary). The highly selective MOR agonist enkephalin analog 3 Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol (DAMGO) and nociceptin were obtained from Bachem Holding AG (Bubendorf, Switzerland) 
Animals
For membrane homogenate preparations male Wistar rats (250-300 g body weight) were used. Rats were housed in the local animal house of BRC (Szeged, Hungary). Animals were kept in a temperature controlled room (21-24 o C) under a 12:12 light and dark cycle and were provided with water and food ad libitum. All housing and experiments were conducted in accordance with the European Communities Council Directives (2010/63/EU) and the Hungarian Act for the Protection of Animals in Research (XXVIII.tv. 32. §). The total number of animals as well as their suffering was minimized.
Rat membrane preparations
Rats were decapitated and their brains quickly removed. The brains were prepared for membrane preparation according to Benyhe et al. 20 
Radioligand competition binding experiments
Initially the test compounds were incubated together with rat brain membranes containing 0.3-0.5 mg/mL of protein in 3 and 10 µM concentrations, and with ~1 nM [ 3 H]DAMGO or [ 3 H]IleDelt II in 35˚C for 45 min. This was for screening purposes, and if the specific binding of either radioligand was inhibited to the non-specific binding level (0%), the test compounds were further investigated in concentration dependency (0.1 nM-10 µM) with the same conditions for radioligand specific binding inhibition to determine the affinity values (logIC 50 , K i ). Additionally, unlabelled DAMGO and IleDelt II were also incubated together with their labelled counterparts in 3 and 10 µM concentrations for control. Total and nonspecific binding was determined in the absence of ligands and presence of 10 µM unlabeled naloxone, respectively. Following the incubation, the bound and unbound radioligands were separated by rapid vacuum filtration through Whatman GF/C glass fibers and washed three times with 5 mL ice cold 50 mM Tris-HCl (pH 7.4). The radioactivity of the filters was detected in UltimaGold TM MV aqueous scintillation cocktail with Packard Tricarb 2300TR liquid scintillation counter. The competition binding assays were performed in duplicate and repeated at least three times.
Functional [ 35 S]GTPγS binding experiments
In [ 
Data analysis
The specific binding of all radiolabelled compounds was calculated by the subtraction of non-specific binding from total binding and was given in percentage. The data was normalized to total specific binding, which was settled 100%, which in case of 
Calcium influx assay
Ca 2+ responses were measured using FLIPR TETRA and Calcium 4 dye (Molecular Devices). SH-SY5Y cells were plated at 40,000 cells per well in 384 well flat clear-bottom black plate (Corning, NY, USA) and cultured at 37°C in a humidified 5% CO 2 incubator 48 h before assay. The medium was removed and cells loaded with 20 μl/well Calcium 4 dye reconstituted in assay buffer containing (in mM) 140 NaCl, 11.5 glucose, 5.9 KCl, 1.4 MgCl 2 , 1.2 NaH 2 PO 4 , 5 NaHCO 3 , 1.8 CaCl 2 and 10 HEPES pH 7.4 and incubated for 30 min at 37°C in a humidified 5% CO 2 incubator. 
Intrathecal administration
For intrathecal (i.t.) drug delivery, the mice were briefly anesthetized with halothane (2.5%) and a 30-gauge needle attached to a 25 μL microsyringe was inserted between L5-L6 vertebrae. A sudden advancement of the needle accompanied by a slight flick of the tail was used as the indicator for the proper insertion into the subarachnoid space. Peptides or its vehicle in 5-μL volume was then injected slowly.
Formalin test
The procedure applied has been previously described. 22,24 Briefly, s.c. injection of a dilute solution of formalin (1%, 20 μL/paw) into the mice hind paw evokes nociceptive behavior:
licking, biting the injected paw or both, which are considered indices of pain. The nociceptive response shows a biphasic trend, consisting of an early phase from 0 to 10 min after the formalin injection, due to the direct stimulation of peripheral nociceptors, followed by a late prolonged phase occurring from 10 to 40 min, that reflects the response to inflammatory pain. During the test, the mouse was placed in a Plexiglas observation cage (30×14×12 cm), 1 h before the formalin administration to allow it to acclimatize to its surroundings. The total time (s) that the animal spent licking or biting its paw during the formalin-induced early and late phase of nociception was recorded. Experiments were performed 10 min after i.t. treatment.
Tail flick test
The tail flick latency was obtained using a commercial apparatus (Ugo Basile, Italy), equipped by an infrared radiant light source (100 W, 15 V bulb) focused to a photocell utilizing an aluminum parabolic mirror. During the trials the mice were gently hand- 
Data analysis and statistics
Experimental data were expressed as mean ± S.E.M. The significance among groups was evaluated with the analysis of variance followed by Dunnett's correction for multiple comparisons using the statistical software GraphPad Prism 6.03. Statistical significance was assumed at P < 0.05. 
